EVALUATION OF THE COST EFFECTIVENESS OF THE TREATMENT OF MILD AND MODERATE ALZHEIMER'S DISEASE

被引：0
|
作者：
Langsch, L. R. [1 ]
机构：
[1] Univ Estado Rio de Janeiro, Sao Pedro Da Aldeia, Brazil
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2479
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM9
引用
收藏
页码：A860 / A860
页数：1
相关论文
共 50 条
  • [11] Masitinib for the treatment of mild to moderate Alzheimer's disease
    Folch, Jaume
    Petrov, Dmitry
    Ettcheto, Miren
    Pedros, Ignacio
    Abad, Sonia
    Beas-Zarate, Carlos
    Lazarowski, Alberto
    Marin, Miguel
    Olloquequi, Jordi
    Auladell, Carme
    Camins, Antoni
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 587 - 596
  • [12] Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer’s DiseaseA UK Evaluation Using Discrete-Event Simulation
    Denis Getsios
    Steve Blume
    K. Jack Ishak
    Grant D. H. Maclaine
    PharmacoEconomics, 2010, 28 : 411 - 427
  • [13] COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY
    Toumi, M.
    Lamure, M.
    Grishchenko, M.
    Cochran, J.
    Rive, B.
    VALUE IN HEALTH, 2009, 12 (07) : A370 - A370
  • [14] THE SAFETY AND EFFECTIVENESS OF IMMUNE GLOBULIN INTRAVENOUS (HUMAN), FOR THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
    Gelmont, David
    NEUROBIOLOGY OF AGING, 2012, 33 : S13 - S13
  • [15] COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
    Turongkaravee, S.
    VALUE IN HEALTH, 2010, 13 (07) : A502 - A502
  • [16] Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
    Migliaccio-Walle, K
    Getsios, D
    Caro, JJ
    Ishak, KJ
    O'Brien, JA
    Papadopoulos, G
    CLINICAL THERAPEUTICS, 2003, 25 (06) : 1806 - 1825
  • [17] Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
    Imbimbo, Bruno P.
    Ottonello, Simone
    Frisardi, Vincenza
    Solfrizzi, Vincenzo
    Greco, Antonio
    Seripa, Davide
    Pilotto, Alberto
    Panza, Francesco
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (02) : 135 - 149
  • [18] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [19] Intravenous immunoglobulin for treatment of mild to moderate Alzheimer's disease
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) : 461 - 461
  • [20] Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease
    Grossberg, G. T.
    Sadowsky, C.
    Olin, J. T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 651 - 660
12345